OPZELURA is a Janus kinase (JAK) inhibitor indicated for the topical shortterm and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable